Welcome to our dedicated page for Honest Company SEC filings (Ticker: HNST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Honest Company's SEC filings document the public-company record for a Delaware consumer products issuer focused on cleanly-formulated personal care and household essentials. Form 8-K reports include quarterly financial results, outlook commentary, non-GAAP measures, and business updates tied to wipes, personal care and portfolio focus under Powering Honest Growth.
Other filings cover governance and capital-structure matters, including definitive proxy materials for director elections and auditor ratification, amendments to a senior secured revolving credit facility and related pledge and security arrangements, executive severance and change-in-control benefits, and exit or disposal activities associated with category, channel and cost-structure changes.
The Honest Company, Inc. (HNST) filed a Form 144 proposing the sale of 12,059 shares of common stock through E*Trade on 08/20/2025 for an aggregate market value of $44,015.35. The shares were acquired on 08/19/2025 upon vesting of Restricted Stock Units awarded under the Issuer's 2021 Equity Incentive Plan, totaling 32,657 shares acquired on that date and paid as equity compensation. The filing reports 111,269,491 shares outstanding. It also discloses a prior sale by the same person of 12,017 shares on 05/21/2025 for gross proceeds of $63,930.44. The notice includes the required representation that the seller is not aware of undisclosed material information.
The Honest Company, Inc. (HNST) Form 144 shows a proposed sale of 4,969 restricted common shares acquired from the issuer on 08/19/2025. The sale is listed with Morgan Stanley Smith Barney on NASDAQ with an approximate aggregate market value of $18,037.47 and the company reported 111,269,491 shares outstanding.
The filing also lists recent disposals by the same person: 29,433 shares sold on 08/20/2025 for gross proceeds of $107,558.64, and 6,176 shares sold on 08/11/2025 for $24,046.26. The filer certifies no undisclosed material adverse information; no additional remarks or a 10b5-1 plan date are provided in the form.
Katherine Barton, the Chief Growth Officer of Honest Company (HNST), reported a sale of 6,176 shares of common stock on 08/11/2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025, and executed at a weighted average price of $3.89 (individual trade prices ranged from $3.785 to $3.95).
After the reported transactions, the reporting person beneficially owns 926,996 shares, held directly. That total expressly includes 622,833 restricted stock units that are payable in an equivalent number of shares of the issuer's common stock.
The Honest Company (HNST) Form 144 notifies a proposed sale under Rule 144 of 6,176 common shares with an aggregate market value of $24,046.26. The shares were acquired as restricted stock on 05/19/2025 and the filing lists an approximate sale date of 08/11/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filing also records that Katherine E Barton sold 21,389 shares on 05/21/2025 for $113,765.95.
The notice provides the basic transactional facts required by Rule 144 but contains no commentary on company operations, material disclosures, or trading plans. It documents the broker, the class of securities, acquisition nature, outstanding shares count of 111,269,491, and recent related sales, giving investors a record of proposed insider selling activity without additional context.
Form 4 filing for The Honest Company, Inc. (HNST) discloses an initial equity award to newly appointed Chief Financial Officer Bruce Curtiss James III. On 1 July 2025, the company granted 202,880 restricted stock units (RSUs) under the 2023 Inducement Plan at a cost basis of $0.00. The RSUs convert to common stock on vesting and increase the executive’s direct beneficial ownership to the same number of shares.
Vesting schedule: 25 % of the award vests on 19 May 2026; the remaining 75 % vests in equal 6.25 % quarterly tranches thereafter, contingent upon continued employment. No derivative securities or sales were reported.
The filing signals a retention-focused compensation structure that more closely aligns the CFO’s incentives with long-term shareholder value. While the share count is modest relative to HNST’s 94 million shares outstanding (≈0.2 % potential dilution), it represents meaningful personal exposure for the executive without immediate cash outlay by the company.